13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13G Filed 2026-10-07 Event — SEC 0001137774-26-000205 →

PRUDENTIAL FINANCIAL INC → Neurogene Inc. NGNE

Stake: — Shares: — Class: Common

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
2 transactions
0 buys · 2 sales · 0 awards/exercises
Issuer Cluster
7 13D/G filings on this issuer
6 other filings besides this one
Filer Track Record
3 filings by this filer
2 other filings in the data moat
Short Interest · settle 2026-09-30
DTC 11.73
4,974,749 shares short · +51.7% vs prior

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-07-07 Cvijic Christine Mikail director, officer Sale 4,200 $36.13 $152K
2026-07-06 Cvijic Christine Mikail director, officer Sale 600 $36.02 $22K

Other 13D/G Filings on Neurogene Inc.

FiledFormFilerStakeShares
2026-10-06 SCHEDULE 13G JENNISON ASSOCIATES LLC — — view →
2023-10-10 SC BAKER BROS. ADVISORS LP — — view →
2023-07-19 SC BAKER BROS. ADVISORS LP — — view →
2019-12-20 SC BAKER BROS. ADVISORS LP — — view →
2019-08-13 SC BAKER BROS. ADVISORS LP — — view →
2018-01-09 SC BlackRock Inc. — — view →

Other Filings by PRUDENTIAL FINANCIAL INC

FiledFormIssuerStakeShares
2026-07-08 SCHEDULE 13G National Healthcare Properties, Inc. NHPAP — — view →
2018-01-09 SC TORTOISE MLP FUND, INC. — — view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →